Market research
600976.SHG Jianmin Pharmaceutical Group Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 4B
- P/E ratio
- 13.02
- Analyst target
- 87.74
- Dividend yield
- 3.4%
- Beta
- 0.07
Community
Investor discussion
1 comment
Sign in to join the 600976.SHG discussion.
5 years, 5 months ago
Jianmin Pharmaceutical Group Co., Ltd is currently in a long term uptrend where the price is trading 67.8% above its 200 day moving average.
From a valuation standpoint, the stock is 83.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.
Jianmin Pharmaceutical Group Co., Ltd's total revenue rose by 108.9% to $850M since the same quarter in the previous year.
Its net income has increased by 21.9% to $22M since the same quarter in the previous year.
Finally, its free cash flow fell by 22.8% to $47M since the same quarter in the previous year.
Based on the above factors, Jianmin Pharmaceutical Group Co., Ltd gets an overall score of 4/5.